Production (Stage)
Surgery Partners, Inc.
SGRY
$22.80
$0.200.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.70M | -108.50M | -31.70M | -15.50M | -12.40M |
| Total Depreciation and Amortization | 36.30M | 33.90M | 50.20M | 34.80M | 33.70M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 64.30M | 217.50M | 74.90M | 85.00M | 57.10M |
| Change in Net Operating Assets | -56.90M | -31.50M | -28.20M | -21.50M | -37.70M |
| Cash from Operations | 6.00M | 111.40M | 65.20M | 82.80M | 40.70M |
| Capital Expenditure | -22.70M | -22.30M | -20.20M | -26.90M | -21.00M |
| Sale of Property, Plant, and Equipment | 4.80M | 1.10M | 0.00 | 0.00 | 1.50M |
| Cash Acquisitions | -44.00M | -87.60M | -26.60M | -210.00M | -54.60M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -14.50M | -2.90M | -2.80M | -7.20M | -9.00M |
| Cash from Investing | -76.40M | -111.70M | -49.60M | -244.10M | -83.10M |
| Total Debt Issued | 213.60M | 265.90M | 168.40M | 1.10B | 192.50M |
| Total Debt Repaid | -119.30M | -170.50M | -135.00M | -853.60M | -120.20M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -64.10M | -47.40M | -40.70M | -59.70M | -40.60M |
| Cash from Financing | 30.20M | 48.00M | -7.30M | 189.60M | 31.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.20M | 47.70M | 8.30M | 28.30M | -10.70M |